List of works by Pasquale Rescigno

Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients

scientific article published on 01 April 2009

Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.

scientific article

CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.

scientific article published on 5 April 2017

Cabazitaxel in castration resistant prostate cancer with brain metastases: 3 case reports

scientific article published on June 2014

Chemical or Surgical Castration--Is This Still an Important Question?

scientific article published on 01 April 2016

Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.

scientific article published on 27 April 2017

Circulating biomarkers of neuroendocrine prostate cancer: an unmet challenge

scientific article published on 01 January 2017

Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.

scientific article published on 10 April 2018

Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.

scientific article published on 10 September 2012

Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.

scientific article published on 29 January 2018

Combination of docetaxel and cetuximab for penile cancer: a case report and literature review

scientific article published on June 2012

Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer

scientific article published on 10 August 2017

Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.

scientific article published on 22 November 2016

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital

scientific article published on 26 April 2017

EpCAM and EpCAM circulating tumor cells in metastatic prostate and breast cancer patients

scientific article published on 02 November 2018

HER3 Is an Actionable Target in Advanced Prostate Cancer

scientific article published on 09 November 2021

Immunotherapy for lethal prostate cancer

scientific article published on 01 February 2019

Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey

scientific article published on 10 October 2016

Long lasting response to second-line everolimus in kidney cancer.

scientific article published on August 2013

New hypothesis on pathogenesis of ovarian cancer lead to future tailored approaches.

scientific article published on 25 August 2013

New perspectives in the therapy of castration resistant prostate cancer.

scientific article published on December 2012

Non-AIDS-related Kaposi's sarcoma: A single-institution experience.

scientific article published on May 2013

P07: Effectiveness of cytotoxic agent etoposide after target therapy in advanced thymic tumors

scientific article published in December 2015

P08: Somatostatin analogs plus prednisone in aggressive histotype and advanced stage of thymic epithelial tumors.

scientific article published in December 2015

P12: Somatostatin analogs as maintenance therapy in heavily pretreated thymic epithelial tumors.

scientific article published in December 2015

PTEN protein loss and clinical outcome from castration-resistant prostate cancer treated with abiraterone acetate.

scientific article published on 4 November 2014

Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study

scientific article published on 22 August 2011

Peg-filgrastim and cabazitaxel in prostate cancer patients.

scientific article published on January 2013

Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer

scientific article

Phase II trial of cisplatin plus prednisone in docetaxel-refractory castration-resistant prostate cancer patients.

scientific article published on 2 March 2011

Plasma AR and abiraterone-resistant prostate cancer.

scientific article

Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.

scientific article published on June 2013

Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer.

scientific article published on 7 March 2016

RB1 Heterogeneity in Advanced Metastatic Castration Resistant Prostate Cancer

scientific article published on 26 September 2018

Reply to Vincenza Conteduca, Cristian Lolli, and Ugo De Giorgi's Letter to the Editor re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall S

scientific article

SPOP-Mutated/CHD1-Deleted Lethal Prostate Cancer and Abiraterone Sensitivity

scientific article published on 01 August 2018

Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis

scientific article published on 09 August 2018

The economic crisis and cancer chemotherapy: the role of the oncologist

scientific article published on 01 July 2012

The potential detrimental effect of corticosteroids in prostate cancer.

scientific article

Third-line sorafenib after sequential therapy with sunitinib and mTOR inhibitors in metastatic renal cell carcinoma.

scientific article published on 24 September 2010

Tumor-to-tumor metastasis: breast cancer metastatic to thymic epithelial tumor

scientific article published on 01 August 2013

Paulina is supported by:

About Paulina

Help